Metabolic Acidosis Market is segmented By Type (Acute Metabolic Acidosis (Drug-induced Acidosis, Lactic Acidosis), Chronic Metabolic Acidosis (Renal T....
Market Size in USD
CAGR5.89%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 5.89% |
Market Concentration | High |
Major Players | Tisento Therapeutics, Tricida, Advicenne Pharma, Zagociguat, Novartis |
The metabolic acidosis market is estimated to be valued at USD 177.9 Mn in 2024 and is expected to reach USD 265.5 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.89% from 2024 to 2031. The growing geriatric population who are more prone to developing metabolic acidosis due to age-related medical conditions such as kidney diseases is a major factor driving the demand.